tiprankstipranks
Trending News
More News >
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Revenue

Compare
265 Followers

Gain Therapeutics Revenue

Gain Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2024, with ―. This bring the company's revenue in the last twelve months to 64.80K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Gain Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
64.80K
Revenue Growth
-100.00%
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
23
Market Cap
$46.77M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20240.00-55.18K-100.00%
Dec 31, 202355.18K-84.93K-60.62%
Dec 31, 2022140.11K-24.89K-15.08%
Dec 31, 2021164.99K136.11K+471.29%
Dec 31, 202028.88K-12.42K-30.07%
Dec 31, 201941.30K20.69K+100.40%
Dec 31, 201820.61K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis